Click for best price
Drugs for Osteoarthritis Pain Market Size, Share 2023
| Market size in 2022 |
US$ 9506 million
|
Forecast Market size by 2029 |
US$ 13960 million
|
| Growth Rate |
CAGR of 5.6% |
Number of Pages |
106 Pages |
Drugs for Osteoarthritis Pain market, the main role of osteoarthritis pain drugs is to relieve pain, and cannot slow the progress of osteoarthritis.
This report aims to provide a comprehensive presentation of the global market for Drugs for Osteoarthritis Pain, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Drugs for Osteoarthritis Pain. This report contains market size and forecasts of Drugs for Osteoarthritis Pain in global, including the following market information:
Global Drugs for Osteoarthritis Pain Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global Drugs for Osteoarthritis Pain market was valued at US$ 9506 million in 2022 and is projected to reach US$ 13960 million by 2029, at a CAGR of 5.6% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
North America is the largest Drugs for Osteoarthritis Pain market with about 36% market share. Europe is follower, accounting for about 27% market share.
The key players are Pfizer, Johnson & Johnson, GlaxoSmithKline, Bayer, Eli Lilly, Novartis, Sanofi, Horizon Pharma, Abbott, Mylan, Daiichi Sankyo, TEVA, Almatica Pharma, Astellas Pharma, Tide Pharmaceutical, Iroko Pharmaceuticals, Hengrui Pharmaceutical, Abiogen Pharma etc. Top 5 companies occupied about 66% market share.
We surveyed the Drugs for Osteoarthritis Pain companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Drugs for Osteoarthritis Pain Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Drugs for Osteoarthritis Pain Market Segment Percentages, by Type, 2022 (%)
Oral
Injection
External
Global Drugs for Osteoarthritis Pain Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Drugs for Osteoarthritis Pain Market Segment Percentages, by Application, 2022 (%)
Medical Care
Personal Care
Global Drugs for Osteoarthritis Pain Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Drugs for Osteoarthritis Pain Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Drugs for Osteoarthritis Pain revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Drugs for Osteoarthritis Pain revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Pfizer
Johnson & Johnson
GlaxoSmithKline
Bayer
Eli Lilly
Novartis
Sanofi
Horizon Pharma
Abbott
Mylan
Daiichi Sankyo
TEVA
Almatica Pharma
Astellas Pharma
Tide Pharmaceutical
Iroko Pharmaceuticals
Hengrui Pharmaceutical
Abiogen Pharma
Outline of Major Chapters:
Chapter 1: Introduces the definition of Drugs for Osteoarthritis Pain, market overview.
Chapter 2: Global Drugs for Osteoarthritis Pain market size in revenue.
Chapter 3: Detailed analysis of Drugs for Osteoarthritis Pain company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Drugs for Osteoarthritis Pain in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
| Report Attributes |
Report Details |
| Report Title |
Drugs for Osteoarthritis Pain Market, Global Outlook and Forecast 2023-2029 |
| Market size in 2022 |
US$ 9506 million
|
| Forecast Market size by 2029 |
US$ 13960 million
|
| Growth Rate |
CAGR of 5.6% |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2022 |
| Forecast Year |
2030 |
| Number of Pages |
106 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Drugs for Osteoarthritis Pain Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Drugs for Osteoarthritis Pain Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Drugs for Osteoarthritis Pain Overall Market Size
2.1 Global Drugs for Osteoarthritis Pain Market Size: 2022 VS 2029
2.2 Global Drugs for Osteoarthritis Pain Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Drugs for Osteoarthritis Pain Players in Global Market
3.2 Top Global Drugs for Osteoarthritis Pain Companies Ranked by Revenue
3.3 Global Drugs for Osteoarthritis Pain Revenue by Companies
3.4 Top 3 and Top 5 Drugs for Osteoarthritis Pain Companies in Global Market, by Revenue in 2022
3.5 Global Companies Drugs for Osteoarthritis Pain Product Type
3.6 Tier 1, Tier 2 and Tier 3 Drugs for Osteoarthritis Pain Players in Global Market
3.6.1 List of Global Tier 1 Drugs for Osteoarthritis Pain Companies
3.6.2 List of Global Tier 2 and Tier 3 Drugs for Osteoarthritis Pain Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Drugs for Osteoarthritis Pain Market Size Markets, 2022 & 2029
4.1.2 Oral
4.1.3 Injection
4.1.4 External
4.2 By Type - Global Drugs for Osteoarthritis Pain Revenue & Forecasts
4.2.1 By Type - Global Drugs for Osteoarthritis Pain Revenue, 2018-2023
4.2.2 By Type - Global Drugs for Osteoarthritis Pain Revenue, 2024-2029
4.2.3 By Type - Global Drugs for Osteoarthritis Pain Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Drugs for Osteoarthritis Pain Market Size, 2022 & 2029
5.1.2 Medical Care
5.1.3 Personal Care
5.2 By Application - Global Drugs for Osteoarthritis Pain Revenue & Forecasts
5.2.1 By Application - Global Drugs for Osteoarthritis Pain Revenue, 2018-2023
5.2.2 By Application - Global Drugs for Osteoarthritis Pain Revenue, 2024-2029
5.2.3 By Application - Global Drugs for Osteoarthritis Pain Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region - Global Drugs for Osteoarthritis Pain Market Size, 2022 & 2029
6.2 By Region - Global Drugs for Osteoarthritis Pain Revenue & Forecasts
6.2.1 By Region - Global Drugs for Osteoarthritis Pain Revenue, 2018-2023
6.2.2 By Region - Global Drugs for Osteoarthritis Pain Revenue, 2024-2029
6.2.3 By Region - Global Drugs for Osteoarthritis Pain Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country - North America Drugs for Osteoarthritis Pain Revenue, 2018-2029
6.3.2 US Drugs for Osteoarthritis Pain Market Size, 2018-2029
6.3.3 Canada Drugs for Osteoarthritis Pain Market Size, 2018-2029
6.3.4 Mexico Drugs for Osteoarthritis Pain Market Size, 2018-2029
6.4 Europe
6.4.1 By Country - Europe Drugs for Osteoarthritis Pain Revenue, 2018-2029
6.4.2 Germany Drugs for Osteoarthritis Pain Market Size, 2018-2029
6.4.3 France Drugs for Osteoarthritis Pain Market Size, 2018-2029
6.4.4 U.K. Drugs for Osteoarthritis Pain Market Size, 2018-2029
6.4.5 Italy Drugs for Osteoarthritis Pain Market Size, 2018-2029
6.4.6 Russia Drugs for Osteoarthritis Pain Market Size, 2018-2029
6.4.7 Nordic Countries Drugs for Osteoarthritis Pain Market Size, 2018-2029
6.4.8 Benelux Drugs for Osteoarthritis Pain Market Size, 2018-2029
6.5 Asia
6.5.1 By Region - Asia Drugs for Osteoarthritis Pain Revenue, 2018-2029
6.5.2 China Drugs for Osteoarthritis Pain Market Size, 2018-2029
6.5.3 Japan Drugs for Osteoarthritis Pain Market Size, 2018-2029
6.5.4 South Korea Drugs for Osteoarthritis Pain Market Size, 2018-2029
6.5.5 Southeast Asia Drugs for Osteoarthritis Pain Market Size, 2018-2029
6.5.6 India Drugs for Osteoarthritis Pain Market Size, 2018-2029
6.6 South America
6.6.1 By Country - South America Drugs for Osteoarthritis Pain Revenue, 2018-2029
6.6.2 Brazil Drugs for Osteoarthritis Pain Market Size, 2018-2029
6.6.3 Argentina Drugs for Osteoarthritis Pain Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Drugs for Osteoarthritis Pain Revenue, 2018-2029
6.7.2 Turkey Drugs for Osteoarthritis Pain Market Size, 2018-2029
6.7.3 Israel Drugs for Osteoarthritis Pain Market Size, 2018-2029
6.7.4 Saudi Arabia Drugs for Osteoarthritis Pain Market Size, 2018-2029
6.7.5 UAE Drugs for Osteoarthritis Pain Market Size, 2018-2029
7 Drugs for Osteoarthritis Pain Companies Profiles
7.1 Pfizer
7.1.1 Pfizer Company Summary
7.1.2 Pfizer Business Overview
7.1.3 Pfizer Drugs for Osteoarthritis Pain Major Product Offerings
7.1.4 Pfizer Drugs for Osteoarthritis Pain Revenue in Global Market (2018-2023)
7.1.5 Pfizer Key News & Latest Developments
7.2 Johnson & Johnson
7.2.1 Johnson & Johnson Company Summary
7.2.2 Johnson & Johnson Business Overview
7.2.3 Johnson & Johnson Drugs for Osteoarthritis Pain Major Product Offerings
7.2.4 Johnson & Johnson Drugs for Osteoarthritis Pain Revenue in Global Market (2018-2023)
7.2.5 Johnson & Johnson Key News & Latest Developments
7.3 GlaxoSmithKline
7.3.1 GlaxoSmithKline Company Summary
7.3.2 GlaxoSmithKline Business Overview
7.3.3 GlaxoSmithKline Drugs for Osteoarthritis Pain Major Product Offerings
7.3.4 GlaxoSmithKline Drugs for Osteoarthritis Pain Revenue in Global Market (2018-2023)
7.3.5 GlaxoSmithKline Key News & Latest Developments
7.4 Bayer
7.4.1 Bayer Company Summary
7.4.2 Bayer Business Overview
7.4.3 Bayer Drugs for Osteoarthritis Pain Major Product Offerings
7.4.4 Bayer Drugs for Osteoarthritis Pain Revenue in Global Market (2018-2023)
7.4.5 Bayer Key News & Latest Developments
7.5 Eli Lilly
7.5.1 Eli Lilly Company Summary
7.5.2 Eli Lilly Business Overview
7.5.3 Eli Lilly Drugs for Osteoarthritis Pain Major Product Offerings
7.5.4 Eli Lilly Drugs for Osteoarthritis Pain Revenue in Global Market (2018-2023)
7.5.5 Eli Lilly Key News & Latest Developments
7.6 Novartis
7.6.1 Novartis Company Summary
7.6.2 Novartis Business Overview
7.6.3 Novartis Drugs for Osteoarthritis Pain Major Product Offerings
7.6.4 Novartis Drugs for Osteoarthritis Pain Revenue in Global Market (2018-2023)
7.6.5 Novartis Key News & Latest Developments
7.7 Sanofi
7.7.1 Sanofi Company Summary
7.7.2 Sanofi Business Overview
7.7.3 Sanofi Drugs for Osteoarthritis Pain Major Product Offerings
7.7.4 Sanofi Drugs for Osteoarthritis Pain Revenue in Global Market (2018-2023)
7.7.5 Sanofi Key News & Latest Developments
7.8 Horizon Pharma
7.8.1 Horizon Pharma Company Summary
7.8.2 Horizon Pharma Business Overview
7.8.3 Horizon Pharma Drugs for Osteoarthritis Pain Major Product Offerings
7.8.4 Horizon Pharma Drugs for Osteoarthritis Pain Revenue in Global Market (2018-2023)
7.8.5 Horizon Pharma Key News & Latest Developments
7.9 Abbott
7.9.1 Abbott Company Summary
7.9.2 Abbott Business Overview
7.9.3 Abbott Drugs for Osteoarthritis Pain Major Product Offerings
7.9.4 Abbott Drugs for Osteoarthritis Pain Revenue in Global Market (2018-2023)
7.9.5 Abbott Key News & Latest Developments
7.10 Mylan
7.10.1 Mylan Company Summary
7.10.2 Mylan Business Overview
7.10.3 Mylan Drugs for Osteoarthritis Pain Major Product Offerings
7.10.4 Mylan Drugs for Osteoarthritis Pain Revenue in Global Market (2018-2023)
7.10.5 Mylan Key News & Latest Developments
7.11 Daiichi Sankyo
7.11.1 Daiichi Sankyo Company Summary
7.11.2 Daiichi Sankyo Business Overview
7.11.3 Daiichi Sankyo Drugs for Osteoarthritis Pain Major Product Offerings
7.11.4 Daiichi Sankyo Drugs for Osteoarthritis Pain Revenue in Global Market (2018-2023)
7.11.5 Daiichi Sankyo Key News & Latest Developments
7.12 TEVA
7.12.1 TEVA Company Summary
7.12.2 TEVA Business Overview
7.12.3 TEVA Drugs for Osteoarthritis Pain Major Product Offerings
7.12.4 TEVA Drugs for Osteoarthritis Pain Revenue in Global Market (2018-2023)
7.12.5 TEVA Key News & Latest Developments
7.13 Almatica Pharma
7.13.1 Almatica Pharma Company Summary
7.13.2 Almatica Pharma Business Overview
7.13.3 Almatica Pharma Drugs for Osteoarthritis Pain Major Product Offerings
7.13.4 Almatica Pharma Drugs for Osteoarthritis Pain Revenue in Global Market (2018-2023)
7.13.5 Almatica Pharma Key News & Latest Developments
7.14 Astellas Pharma
7.14.1 Astellas Pharma Company Summary
7.14.2 Astellas Pharma Business Overview
7.14.3 Astellas Pharma Drugs for Osteoarthritis Pain Major Product Offerings
7.14.4 Astellas Pharma Drugs for Osteoarthritis Pain Revenue in Global Market (2018-2023)
7.14.5 Astellas Pharma Key News & Latest Developments
7.15 Tide Pharmaceutical
7.15.1 Tide Pharmaceutical Company Summary
7.15.2 Tide Pharmaceutical Business Overview
7.15.3 Tide Pharmaceutical Drugs for Osteoarthritis Pain Major Product Offerings
7.15.4 Tide Pharmaceutical Drugs for Osteoarthritis Pain Revenue in Global Market (2018-2023)
7.15.5 Tide Pharmaceutical Key News & Latest Developments
7.16 Iroko Pharmaceuticals
7.16.1 Iroko Pharmaceuticals Company Summary
7.16.2 Iroko Pharmaceuticals Business Overview
7.16.3 Iroko Pharmaceuticals Drugs for Osteoarthritis Pain Major Product Offerings
7.16.4 Iroko Pharmaceuticals Drugs for Osteoarthritis Pain Revenue in Global Market (2018-2023)
7.16.5 Iroko Pharmaceuticals Key News & Latest Developments
7.17 Hengrui Pharmaceutical
7.17.1 Hengrui Pharmaceutical Company Summary
7.17.2 Hengrui Pharmaceutical Business Overview
7.17.3 Hengrui Pharmaceutical Drugs for Osteoarthritis Pain Major Product Offerings
7.17.4 Hengrui Pharmaceutical Drugs for Osteoarthritis Pain Revenue in Global Market (2018-2023)
7.17.5 Hengrui Pharmaceutical Key News & Latest Developments
7.18 Abiogen Pharma
7.18.1 Abiogen Pharma Company Summary
7.18.2 Abiogen Pharma Business Overview
7.18.3 Abiogen Pharma Drugs for Osteoarthritis Pain Major Product Offerings
7.18.4 Abiogen Pharma Drugs for Osteoarthritis Pain Revenue in Global Market (2018-2023)
7.18.5 Abiogen Pharma Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Drugs for Osteoarthritis Pain Market Opportunities & Trends in Global Market
Table 2. Drugs for Osteoarthritis Pain Market Drivers in Global Market
Table 3. Drugs for Osteoarthritis Pain Market Restraints in Global Market
Table 4. Key Players of Drugs for Osteoarthritis Pain in Global Market
Table 5. Top Drugs for Osteoarthritis Pain Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Drugs for Osteoarthritis Pain Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Drugs for Osteoarthritis Pain Revenue Share by Companies, 2018-2023
Table 8. Global Companies Drugs for Osteoarthritis Pain Product Type
Table 9. List of Global Tier 1 Drugs for Osteoarthritis Pain Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Drugs for Osteoarthritis Pain Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Drugs for Osteoarthritis Pain Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Drugs for Osteoarthritis Pain Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Drugs for Osteoarthritis Pain Revenue in Global (US$, Mn), 2024-2029
Table 14. By Application ? Global Drugs for Osteoarthritis Pain Revenue, (US$, Mn), 2022 & 2029
Table 15. By Application - Drugs for Osteoarthritis Pain Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Drugs for Osteoarthritis Pain Revenue in Global (US$, Mn), 2024-2029
Table 17. By Region ? Global Drugs for Osteoarthritis Pain Revenue, (US$, Mn), 2022 & 2029
Table 18. By Region - Global Drugs for Osteoarthritis Pain Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Drugs for Osteoarthritis Pain Revenue (US$, Mn), 2024-2029
Table 20. By Country - North America Drugs for Osteoarthritis Pain Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Drugs for Osteoarthritis Pain Revenue, (US$, Mn), 2024-2029
Table 22. By Country - Europe Drugs for Osteoarthritis Pain Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Drugs for Osteoarthritis Pain Revenue, (US$, Mn), 2024-2029
Table 24. By Region - Asia Drugs for Osteoarthritis Pain Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Drugs for Osteoarthritis Pain Revenue, (US$, Mn), 2024-2029
Table 26. By Country - South America Drugs for Osteoarthritis Pain Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Drugs for Osteoarthritis Pain Revenue, (US$, Mn), 2024-2029
Table 28. By Country - Middle East & Africa Drugs for Osteoarthritis Pain Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Drugs for Osteoarthritis Pain Revenue, (US$, Mn), 2024-2029
Table 30. Pfizer Company Summary
Table 31. Pfizer Drugs for Osteoarthritis Pain Product Offerings
Table 32. Pfizer Drugs for Osteoarthritis Pain Revenue (US$, Mn) & (2018-2023)
Table 33. Pfizer Key News & Latest Developments
Table 34. Johnson & Johnson Company Summary
Table 35. Johnson & Johnson Drugs for Osteoarthritis Pain Product Offerings
Table 36. Johnson & Johnson Drugs for Osteoarthritis Pain Revenue (US$, Mn) & (2018-2023)
Table 37. Johnson & Johnson Key News & Latest Developments
Table 38. GlaxoSmithKline Company Summary
Table 39. GlaxoSmithKline Drugs for Osteoarthritis Pain Product Offerings
Table 40. GlaxoSmithKline Drugs for Osteoarthritis Pain Revenue (US$, Mn) & (2018-2023)
Table 41. GlaxoSmithKline Key News & Latest Developments
Table 42. Bayer Company Summary
Table 43. Bayer Drugs for Osteoarthritis Pain Product Offerings
Table 44. Bayer Drugs for Osteoarthritis Pain Revenue (US$, Mn) & (2018-2023)
Table 45. Bayer Key News & Latest Developments
Table 46. Eli Lilly Company Summary
Table 47. Eli Lilly Drugs for Osteoarthritis Pain Product Offerings
Table 48. Eli Lilly Drugs for Osteoarthritis Pain Revenue (US$, Mn) & (2018-2023)
Table 49. Eli Lilly Key News & Latest Developments
Table 50. Novartis Company Summary
Table 51. Novartis Drugs for Osteoarthritis Pain Product Offerings
Table 52. Novartis Drugs for Osteoarthritis Pain Revenue (US$, Mn) & (2018-2023)
Table 53. Novartis Key News & Latest Developments
Table 54. Sanofi Company Summary
Table 55. Sanofi Drugs for Osteoarthritis Pain Product Offerings
Table 56. Sanofi Drugs for Osteoarthritis Pain Revenue (US$, Mn) & (2018-2023)
Table 57. Sanofi Key News & Latest Developments
Table 58. Horizon Pharma Company Summary
Table 59. Horizon Pharma Drugs for Osteoarthritis Pain Product Offerings
Table 60. Horizon Pharma Drugs for Osteoarthritis Pain Revenue (US$, Mn) & (2018-2023)
Table 61. Horizon Pharma Key News & Latest Developments
Table 62. Abbott Company Summary
Table 63. Abbott Drugs for Osteoarthritis Pain Product Offerings
Table 64. Abbott Drugs for Osteoarthritis Pain Revenue (US$, Mn) & (2018-2023)
Table 65. Abbott Key News & Latest Developments
Table 66. Mylan Company Summary
Table 67. Mylan Drugs for Osteoarthritis Pain Product Offerings
Table 68. Mylan Drugs for Osteoarthritis Pain Revenue (US$, Mn) & (2018-2023)
Table 69. Mylan Key News & Latest Developments
Table 70. Daiichi Sankyo Company Summary
Table 71. Daiichi Sankyo Drugs for Osteoarthritis Pain Product Offerings
Table 72. Daiichi Sankyo Drugs for Osteoarthritis Pain Revenue (US$, Mn) & (2018-2023)
Table 73. Daiichi Sankyo Key News & Latest Developments
Table 74. TEVA Company Summary
Table 75. TEVA Drugs for Osteoarthritis Pain Product Offerings
Table 76. TEVA Drugs for Osteoarthritis Pain Revenue (US$, Mn) & (2018-2023)
Table 77. TEVA Key News & Latest Developments
Table 78. Almatica Pharma Company Summary
Table 79. Almatica Pharma Drugs for Osteoarthritis Pain Product Offerings
Table 80. Almatica Pharma Drugs for Osteoarthritis Pain Revenue (US$, Mn) & (2018-2023)
Table 81. Almatica Pharma Key News & Latest Developments
Table 82. Astellas Pharma Company Summary
Table 83. Astellas Pharma Drugs for Osteoarthritis Pain Product Offerings
Table 84. Astellas Pharma Drugs for Osteoarthritis Pain Revenue (US$, Mn) & (2018-2023)
Table 85. Astellas Pharma Key News & Latest Developments
Table 86. Tide Pharmaceutical Company Summary
Table 87. Tide Pharmaceutical Drugs for Osteoarthritis Pain Product Offerings
Table 88. Tide Pharmaceutical Drugs for Osteoarthritis Pain Revenue (US$, Mn) & (2018-2023)
Table 89. Tide Pharmaceutical Key News & Latest Developments
Table 90. Iroko Pharmaceuticals Company Summary
Table 91. Iroko Pharmaceuticals Drugs for Osteoarthritis Pain Product Offerings
Table 92. Iroko Pharmaceuticals Drugs for Osteoarthritis Pain Revenue (US$, Mn) & (2018-2023)
Table 93. Iroko Pharmaceuticals Key News & Latest Developments
Table 94. Hengrui Pharmaceutical Company Summary
Table 95. Hengrui Pharmaceutical Drugs for Osteoarthritis Pain Product Offerings
Table 96. Hengrui Pharmaceutical Drugs for Osteoarthritis Pain Revenue (US$, Mn) & (2018-2023)
Table 97. Hengrui Pharmaceutical Key News & Latest Developments
Table 98. Abiogen Pharma Company Summary
Table 99. Abiogen Pharma Drugs for Osteoarthritis Pain Product Offerings
Table 100. Abiogen Pharma Drugs for Osteoarthritis Pain Revenue (US$, Mn) & (2018-2023)
Table 101. Abiogen Pharma Key News & Latest Developments
List of Figures
Figure 1. Drugs for Osteoarthritis Pain Segment by Type in 2022
Figure 2. Drugs for Osteoarthritis Pain Segment by Application in 2022
Figure 3. Global Drugs for Osteoarthritis Pain Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Drugs for Osteoarthritis Pain Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Drugs for Osteoarthritis Pain Revenue, 2018-2029 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Drugs for Osteoarthritis Pain Revenue in 2022
Figure 8. By Type - Global Drugs for Osteoarthritis Pain Revenue Market Share, 2018-2029
Figure 9. By Application - Global Drugs for Osteoarthritis Pain Revenue Market Share, 2018-2029
Figure 10. By Type - Global Drugs for Osteoarthritis Pain Revenue, (US$, Mn), 2022 & 2029
Figure 11. By Type - Global Drugs for Osteoarthritis Pain Revenue Market Share, 2018-2029
Figure 12. By Application - Global Drugs for Osteoarthritis Pain Revenue, (US$, Mn), 2022 & 2029
Figure 13. By Application - Global Drugs for Osteoarthritis Pain Revenue Market Share, 2018-2029
Figure 14. By Region - Global Drugs for Osteoarthritis Pain Revenue Market Share, 2018-2029
Figure 15. By Country - North America Drugs for Osteoarthritis Pain Revenue Market Share, 2018-2029
Figure 16. US Drugs for Osteoarthritis Pain Revenue, (US$, Mn), 2018-2029
Figure 17. Canada Drugs for Osteoarthritis Pain Revenue, (US$, Mn), 2018-2029
Figure 18. Mexico Drugs for Osteoarthritis Pain Revenue, (US$, Mn), 2018-2029
Figure 19. By Country - Europe Drugs for Osteoarthritis Pain Revenue Market Share, 2018-2029
Figure 20. Germany Drugs for Osteoarthritis Pain Revenue, (US$, Mn), 2018-2029
Figure 21. France Drugs for Osteoarthritis Pain Revenue, (US$, Mn), 2018-2029
Figure 22. U.K. Drugs for Osteoarthritis Pain Revenue, (US$, Mn), 2018-2029
Figure 23. Italy Drugs for Osteoarthritis Pain Revenue, (US$, Mn), 2018-2029
Figure 24. Russia Drugs for Osteoarthritis Pain Revenue, (US$, Mn), 2018-2029
Figure 25. Nordic Countries Drugs for Osteoarthritis Pain Revenue, (US$, Mn), 2018-2029
Figure 26. Benelux Drugs for Osteoarthritis Pain Revenue, (US$, Mn), 2018-2029
Figure 27. By Region - Asia Drugs for Osteoarthritis Pain Revenue Market Share, 2018-2029
Figure 28. China Drugs for Osteoarthritis Pain Revenue, (US$, Mn), 2018-2029
Figure 29. Japan Drugs for Osteoarthritis Pain Revenue, (US$, Mn), 2018-2029
Figure 30. South Korea Drugs for Osteoarthritis Pain Revenue, (US$, Mn), 2018-2029
Figure 31. Southeast Asia Drugs for Osteoarthritis Pain Revenue, (US$, Mn), 2018-2029
Figure 32. India Drugs for Osteoarthritis Pain Revenue, (US$, Mn), 2018-2029
Figure 33. By Country - South America Drugs for Osteoarthritis Pain Revenue Market Share, 2018-2029
Figure 34. Brazil Drugs for Osteoarthritis Pain Revenue, (US$, Mn), 2018-2029
Figure 35. Argentina Drugs for Osteoarthritis Pain Revenue, (US$, Mn), 2018-2029
Figure 36. By Country - Middle East & Africa Drugs for Osteoarthritis Pain Revenue Market Share, 2018-2029
Figure 37. Turkey Drugs for Osteoarthritis Pain Revenue, (US$, Mn), 2018-2029
Figure 38. Israel Drugs for Osteoarthritis Pain Revenue, (US$, Mn), 2018-2029
Figure 39. Saudi Arabia Drugs for Osteoarthritis Pain Revenue, (US$, Mn), 2018-2029
Figure 40. UAE Drugs for Osteoarthritis Pain Revenue, (US$, Mn), 2018-2029
Figure 41. Pfizer Drugs for Osteoarthritis Pain Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Johnson & Johnson Drugs for Osteoarthritis Pain Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. GlaxoSmithKline Drugs for Osteoarthritis Pain Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Bayer Drugs for Osteoarthritis Pain Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Eli Lilly Drugs for Osteoarthritis Pain Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Novartis Drugs for Osteoarthritis Pain Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Sanofi Drugs for Osteoarthritis Pain Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Horizon Pharma Drugs for Osteoarthritis Pain Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. Abbott Drugs for Osteoarthritis Pain Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. Mylan Drugs for Osteoarthritis Pain Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 51. Daiichi Sankyo Drugs for Osteoarthritis Pain Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 52. TEVA Drugs for Osteoarthritis Pain Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 53. Almatica Pharma Drugs for Osteoarthritis Pain Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 54. Astellas Pharma Drugs for Osteoarthritis Pain Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 55. Tide Pharmaceutical Drugs for Osteoarthritis Pain Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 56. Iroko Pharmaceuticals Drugs for Osteoarthritis Pain Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 57. Hengrui Pharmaceutical Drugs for Osteoarthritis Pain Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 58. Abiogen Pharma Drugs for Osteoarthritis Pain Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
